Microbiology Research Institute, Universidad Nacional Autonoma de Honduras, Tegucigalpa, Honduras.
Panamerican Health Organization, Tegucigalpa, Honduras.
Malar J. 2018 Aug 31;17(1):320. doi: 10.1186/s12936-018-2470-7.
Malaria remains a public health problem in some countries of Central America. Rapid diagnostic tests (RDTs) are one of the most useful tools to assist in the diagnosis of malaria in remote areas. Since its introduction, a wide variety of RDTs have been developed for the detection of different parasite antigens. PfHRP2 is the most targeted antigen for the detection of Plasmodium falciparum infections. Genetic mutations and gene deletions are important factors influencing or affecting the performance of rapid diagnostic tests.
In order to demonstrate the presence or absence of the pfhrp2 and pfhrp3 genes and their flanking regions, a total of 128 blood samples from patients with P. falciparum infection from three Central American countries were analysed through nested or semi-nested PCR approaches.
In total, 25.8 and 91.4% of the isolates lacked the region located between exon 1 and exon 2 of pfhrp2 and pfhrp3 genes, respectively. Parasites from the three countries showed deletions of one or both genes. The highest proportion of pfhrp2 deletions was found in Nicaragua while the isolates from Guatemala revealed the lowest number of pfhrp2 deletions. Parasites collected from Honduras showed the highest proportion of phfrp3 absence (96.2%). Twenty-one percent of isolates were double negative mutants for the exon 1-2 segment of both genes, and 6.3% of isolates lacked the full-length coding region of both genes.
This study provides molecular evidence of the existence of P. falciparum isolates lacking the pfhrp2 and pfhrp3 genes, and their flanking regions, in Honduras, Guatemala and Nicaragua. This finding could hinder progress in the control and elimination of malaria in Central America. Continuous evaluation of RDTs and molecular surveillance would be recommended.
疟疾仍是中美洲一些国家的公共卫生问题。快速诊断检测(RDT)是协助在偏远地区诊断疟疾的最有用工具之一。自问世以来,已经开发出多种用于检测不同寄生虫抗原的 RDT。PfHRP2 是检测恶性疟原虫感染的最靶向抗原。遗传突变和基因缺失是影响或影响快速诊断检测性能的重要因素。
为了证明 pfhrp2 和 pfhrp3 基因及其侧翼区域的存在或不存在,通过巢式或半巢式 PCR 方法分析了来自三个中美洲国家的 128 例恶性疟原虫感染患者的血液样本。
总共有 25.8%和 91.4%的分离株分别缺乏 pfhrp2 和 pfhrp3 基因的exon 1 和 exon 2 之间的区域。来自三个国家的寄生虫均缺失一个或两个基因。尼加拉瓜的 pfhrp2 缺失比例最高,而危地马拉的分离株的 pfhrp2 缺失比例最低。洪都拉斯采集的寄生虫 phfrp3 缺失比例最高(96.2%)。21%的分离株对两个基因的 exon 1-2 片段为双重阴性突变,6.3%的分离株缺失两个基因的全长编码区。
本研究提供了分子证据,证明在洪都拉斯、危地马拉和尼加拉瓜存在缺乏 pfhrp2 和 pfhrp3 基因及其侧翼区域的恶性疟原虫分离株。这一发现可能阻碍中美洲疟疾的控制和消除工作的进展。建议持续评估 RDT 和分子监测。